Two Los Alamos National Laboratory scientists are among the team recently funded to explore ways to create the precise immune factors needed for effective vaccines against HIV.
The Duke University-led consortium will largely concentrate on inducing broadly neutralizing antibodies that can prevent HIV-1 infection, as well as on generating protective T-cell and innate immune system responses.
“A vaccine-elicited broadly neutralizing antibody response has the potential to block HIV infection; T-cell responses will support that response, and are likely to be able to help control and contain the virus if it breaks through the neutralizing antibody response,” said Bette Korber, one of the LANL researchers.
“Some HIV infected individuals eventually make good neutralizing responses during their infection,” she noted. The scientists will use the body’s occasional ability to create these antibodies as roadmaps for candidate vaccines to stimulate protective antibody responses. Los Alamos scientists from the theoretical biology group will provide analyses and design.
If you currently subscribe or have subscribed in the past to the Los Alamos Monitor, then simply find your account number on your mailing label and enter it below.
Click the question mark below to see where your account ID appears on your mailing label.
If you are new to the award winning Los Alamos Monitor and wish to get a subscription or simply gain access to our online content then please enter your ZIP code below and continue to setup your account.
| ZIP Code: | |